Callan JMB Inc. Stock Price, News & Analysis

Callan JMB (NASDAQ:CJMB) entered a preliminary agreement on November 13, 2025 to install an oral drug delivery manufacturer's production equipment at its cGMP facility in Spring Branch, Texas. The collaboration begins a phased effort to combine Callan JMB's cGMP warehousing, licensing, certification, and distribution capabilities with the client's manufacturing technology for fast-dissolving oral strips that offer an alternative to intravenous injections.

The companies are negotiating operational terms while Callan JMB positions this move as part of broader onshoring and manufacturing initiatives with global healthcare partners, including planned efforts with Revival Health.

Callan JMB (NASDAQ: CJMB) announced an expansion of its reclamation and logistics operations into the food sampling sector as part of a multi-variant growth strategy on Nov. 10, 2025. The company will apply its regulated-materials expertise—product integrity, recall readiness, and traceability—to sustainable sampling programs.

Callan JMB cited a partnership with AI platform Keychain (supporting $1B in monthly manufacturing projects and connecting 30,000 manufacturers with 20,000 brands) to accelerate market entry. The release references a global food logistics market > $120B growing 6–10% annually as the expansion rationale.

Callan JMB (NASDAQ:CJMB) announced Sentry 4.0, an upgraded version of its Sentry Monitoring System for temperature-sensitive pharmaceutical storage on Oct 13, 2025.

Sentry 4.0 replaces Java with HTML5, enabling access from any web browser on PC, Mac, iPhone, Android, or tablet without downloads. The system retains 24/7/365 active monitoring, alarm notifications, and compliant reporting while improving user accessibility and consistency across devices. The upgrade is available now to new and existing customers.

Callan JMB (NASDAQ: CJMB) announced that its management team will participate in the LD Micro Main Event XIX on October 19-21, 2025. Presentation is scheduled for October 21, 2025 at 12:00 PM PT at Hotel del Coronado, San Diego, CA. A live webcast will be available at https://ldmicrocasts.com/. For access or questions, contact your LD Micro representative or email CallanJMB@kcsa.com.

Callan JMB (NASDAQ: CJMB), a healthcare logistics services provider, has announced its participation in two upcoming investment conferences in September 2025. The company will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10 at the Lotte New York Palace Hotel, with an on-demand presentation available from September 5.

Additionally, management will participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference on September 16-17, presenting at 10:30 a.m. ET. The company will conduct one-on-one investor meetings during both conferences.

[]

Callan JMB (NASDAQ: CJMB), a healthcare logistics company, reported Q2 2025 financial results and significant business developments. The company recorded Q2 revenues of $1.7 million and a net loss from operations of $1.4 million.

Key developments include a strategic partnership with Revival Health for integrated supply chain services, launch of an Indian subsidiary with planned temperature-controlled facilities in Pune, and extension of Chicago's emergency preparedness contract through June 2026 with a $1.5 million funding increase to $9.1 million total. The company also appointed Christopher Shields as SVP of Emergency Preparedness & Response and successfully managed a measles outbreak response.

Post-quarter, Callan JMB secured a $25 million equity line of credit to support growth initiatives in GLP-1 pharmaceutical distribution, specialty compounding pharmacy logistics, and premium food packaging solutions.

Callan JMB (NASDAQ: CJMB) has secured a contract extension with the City of Chicago through June 2026, marking a significant development in their seven-year partnership. The contract, focused on Health Preparedness Supplies and Related Services, includes a $1.5 million funding increase, bringing the total contract value to $9.1 million.

Through its subsidiary Coldchain Technology Services, Callan JMB will continue providing pallet storage and emergency supplies management services for Chicago residents. The extension ensures uninterrupted service delivery in emergency preparedness and response capabilities.

Callan JMB (NASDAQ: CJMB) has established a new subsidiary, Callan JMB Services (India) Private Limited, to expand its logistics services in India. The company plans to open a temperature-controlled warehouse in Pune, Maharashtra capable of storing pharmaceuticals at various temperatures, including -80°C for tissue samples.

The subsidiary, incorporated on June 20, 2025, will facilitate pharmaceutical distribution within India and help Indian companies establish manufacturing operations in the U.S. The company has already secured an agreement with Walker's Pharmaceuticals and is collaborating with Brihans Natural Products for U.S. manufacturing setup and distribution services.

Callan JMB (NASDAQ: CJMB) successfully managed the redistribution of over 1,300 MMR II vaccine doses from Chicago's Westside CDC to Texas and New Mexico in response to measles outbreaks. The company utilized its specialized cold chain reusable shippers equipped with active temperature monitoring devices to maintain required temperatures during transit. The operation demonstrated efficient vaccine redistribution with zero waste, as all shipping materials were recovered and recertified, preventing any landfill disposal. COO Scott Bullard highlighted the operation as a model for interstate public health collaboration during outbreak responses, showcasing the company's cold chain technology capabilities in ensuring safe vaccine delivery.